vs
Side-by-side financial comparison of FIRST COMMONWEALTH FINANCIAL CORP (FCF) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
FIRST COMMONWEALTH FINANCIAL CORP is the larger business by last-quarter revenue ($133.7M vs $85.1M, roughly 1.6× 4D Molecular Therapeutics, Inc.). FIRST COMMONWEALTH FINANCIAL CORP runs the higher net margin — 28.1% vs 22.8%, a 5.3% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 13.0%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 5.5%).
First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
FCF vs FDMT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $133.7M | $85.1M |
| Net Profit | $37.5M | $19.4M |
| Gross Margin | — | — |
| Operating Margin | — | 17.3% |
| Net Margin | 28.1% | 22.8% |
| Revenue YoY | 13.0% | 8508900.0% |
| Net Profit YoY | 14.8% | 139.1% |
| EPS (diluted) | $0.37 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $133.7M | — | ||
| Q4 25 | $137.9M | $85.1M | ||
| Q3 25 | $136.0M | $90.0K | ||
| Q2 25 | $131.0M | $15.0K | ||
| Q1 25 | $118.0M | $14.0K | ||
| Q4 24 | $120.4M | $1.0K | ||
| Q3 24 | $121.2M | $3.0K | ||
| Q2 24 | $120.2M | $5.0K |
| Q1 26 | $37.5M | — | ||
| Q4 25 | $44.9M | $19.4M | ||
| Q3 25 | $41.3M | $-56.9M | ||
| Q2 25 | $33.4M | $-54.7M | ||
| Q1 25 | $32.7M | $-48.0M | ||
| Q4 24 | $35.8M | — | ||
| Q3 24 | $32.1M | $-43.8M | ||
| Q2 24 | $37.1M | $-35.0M |
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | 17.3% | ||
| Q3 25 | 38.1% | -67983.3% | ||
| Q2 25 | 32.1% | -396373.3% | ||
| Q1 25 | 34.8% | -383007.1% | ||
| Q4 24 | 37.1% | — | ||
| Q3 24 | 33.4% | -1704400.0% | ||
| Q2 24 | 38.7% | -849120.0% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 32.5% | 22.8% | ||
| Q3 25 | 30.4% | -63195.6% | ||
| Q2 25 | 25.5% | -364386.7% | ||
| Q1 25 | 27.7% | -342657.1% | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 26.5% | -1461433.3% | ||
| Q2 24 | 30.9% | -699060.0% |
| Q1 26 | $0.37 | — | ||
| Q4 25 | $0.44 | $0.43 | ||
| Q3 25 | $0.39 | $-1.01 | ||
| Q2 25 | $0.32 | $-0.98 | ||
| Q1 25 | $0.32 | $-0.86 | ||
| Q4 24 | $0.35 | — | ||
| Q3 24 | $0.31 | $-0.79 | ||
| Q2 24 | $0.36 | $-0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $402.7M |
| Total DebtLower is stronger | $154.9M | — |
| Stockholders' EquityBook value | $1.6B | $505.7M |
| Total Assets | $12.3B | $566.7M |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $402.7M | ||
| Q3 25 | — | $305.1M | ||
| Q2 25 | — | $293.2M | ||
| Q1 25 | — | $321.4M | ||
| Q4 24 | — | $424.9M | ||
| Q3 24 | — | $501.9M | ||
| Q2 24 | — | $541.9M |
| Q1 26 | $154.9M | — | ||
| Q4 25 | $261.7M | — | ||
| Q3 25 | $262.1M | — | ||
| Q2 25 | $262.4M | — | ||
| Q1 25 | $262.7M | — | ||
| Q4 24 | $263.0M | — | ||
| Q3 24 | $136.3M | — | ||
| Q2 24 | $136.6M | — |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $505.7M | ||
| Q3 25 | $1.5B | $369.0M | ||
| Q2 25 | $1.5B | $420.9M | ||
| Q1 25 | $1.4B | $469.7M | ||
| Q4 24 | $1.4B | $510.6M | ||
| Q3 24 | $1.4B | $552.9M | ||
| Q2 24 | $1.4B | $588.3M |
| Q1 26 | $12.3B | — | ||
| Q4 25 | $12.3B | $566.7M | ||
| Q3 25 | $12.3B | $424.0M | ||
| Q2 25 | $12.2B | $473.6M | ||
| Q1 25 | $11.8B | $515.7M | ||
| Q4 24 | $11.6B | $560.4M | ||
| Q3 24 | $12.0B | $604.0M | ||
| Q2 24 | $11.6B | $620.1M |
| Q1 26 | 0.10× | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.18× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $28.6M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 33.5% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $187.5M | $28.6M | ||
| Q3 25 | $49.5M | $-46.5M | ||
| Q2 25 | $30.4M | $-43.4M | ||
| Q1 25 | $55.9M | $-47.8M | ||
| Q4 24 | $129.5M | $-134.6M | ||
| Q3 24 | $53.6M | $-29.4M | ||
| Q2 24 | $22.7M | $-30.2M |
| Q1 26 | — | — | ||
| Q4 25 | $171.5M | $28.5M | ||
| Q3 25 | — | $-46.6M | ||
| Q2 25 | — | $-43.4M | ||
| Q1 25 | — | $-48.4M | ||
| Q4 24 | $113.9M | $-138.4M | ||
| Q3 24 | — | $-31.2M | ||
| Q2 24 | — | $-30.6M |
| Q1 26 | — | — | ||
| Q4 25 | 124.3% | 33.5% | ||
| Q3 25 | — | -51765.6% | ||
| Q2 25 | — | -289620.0% | ||
| Q1 25 | — | -345635.7% | ||
| Q4 24 | 94.6% | -13837100.0% | ||
| Q3 24 | — | -1038966.7% | ||
| Q2 24 | — | -611840.0% |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | 0.1% | ||
| Q3 25 | — | 101.1% | ||
| Q2 25 | — | 440.0% | ||
| Q1 25 | — | 4507.1% | ||
| Q4 24 | 12.9% | 378600.0% | ||
| Q3 24 | — | 59266.7% | ||
| Q2 24 | — | 6980.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.18× | 1.47× | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 1.71× | — | ||
| Q4 24 | 3.61× | — | ||
| Q3 24 | 1.67× | — | ||
| Q2 24 | 0.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
